Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins

Journal of Virology

Volumn 79, Issue 19, 2005, Pages 12425-12433

  Gerlach, J T ^a,c   Ulsenheimer, A ^b,c   Gruner N H ^b,c   June, M C ^b,c   Schraut, W ^c   Schirren, C A ^b   Heeg, M ^c   Scholz, S ^c   Witter, K ^c   Zahn, R ^c   Vogler, A ^c   Zachoval, R ^b   Pape, G R ^b,c   Diepolder, H M ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; EPITOPE; HELICASE; HEPATITIS C VACCINE; HLA ANTIGEN; HLA ANTIGEN CLASS 2; NONSTRUCTURAL PROTEIN 3; NS4 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOLESCENT; ADULT; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C; HLA ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 25144508604     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.19.12425-12433.2005     Document Type: Article

References (19)

1. Alter, M. J. 1999. Hepatitis C virus infection in the United States. J. Hepatol. 31:88-91.
2. + T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76:12584-12595.
3. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J. Virol. 71:6011-6019.
4. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
5. Eckels, D. D., H. Zhou, T. H. Bian, and H. Wang. 1999. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int. Immunol. 11:577-583.
6. Farci, P., and R. H. Purcell. 2000. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin. Liver Dis. 20:103-126.
7. + T-cell response in acute hepatitis C. Gastroenterology 117:933-941.
8. + T cell responses in chronically infected and non-viremic patients. Eur. J. Immunol. 31:1438-1446.
9. + T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. J. Viral Hepat. 11:324-331.
10. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21: 632-638.
11. + T cells: implications for vaccine development. Hepatology 30:1088-1098.
12. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp. Med. 191:1499-1512.
13. Lund, O., M. Nielsen, C. Kesmir, A. G. Petersen, C. Lundegaards, P. Worning, C. Sylvester-Hvid, K. Lamberth, G. Roder, S. Justesen, S. Buus, and S. Brunak. 2004. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55:797-810.
14. Missale, G., R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M. G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Investig. 98:706-714.
15. Penna, A., G. Missale, V. Lamonaca, M. Pilli, C. Mori, P. Zanelli, A. Cavalli, G. Elia, and C. Ferrari. 2002. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 35:1225-1236.
16. Rahman, F., T. Heller, Y. Sobao, E. Mizukoshi, M. Nascimbeni, H. Alter, S. Herrine, J. Hoofnagle, T. J. Liang, and B. Rehermann. 2004. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40:87-97.
17. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
18. Tsai, S. L., Y. F. Liaw, M. H. Chen, C. Y. Huang, and G. C. Kuo. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449-458.
19. + T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37:577-589.